Skandinaviska Enskilda Banken (SEB)
MED icon

Skandinaviska Enskilda Banken (SEB)’s Medifast MED Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$96K – 1045
2021
Q3 		$96K Sell
500
-46,200
-99% -$11.4M ﹤0.01% 961
2021
Q2 		$13.2M Buy
46,700
+21,700
+87% +$5.88M 0.08% 240
2021
Q1 		$5.3M Buy
25,000
+17,800
+247% +$4.26M 0.03% 386
2020
Q4 		$1.41M Buy
7,200
+3,600
+100% +$636K 0.01% 744
2020
Q3 		$592K Sell
3,600
-300
-8% -$49.4K ﹤0.01% 810
2020
Q2 		$541K Buy
+3,900
New +$358K ﹤0.01% 801

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s MED Position: Q4 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Medifast (MED) in Q4 2021, closing a stake of 500 shares — an estimated $96K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MED in Q2 2020 and held it in 6 quarters. The position peaked at $13.2M in Q2 2021. 297 funds tracked by Wall St. Rank hold MED as of Q4 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Medifast position as of Q4 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 500 Medifast shares in Q4 2021, an estimated $96K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Medifast in Q2 2020 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Medifast position peaked at $13.2M in Q2 2021.
  • 297 funds tracked by Wall St. Rank held Medifast as of Q4 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2021, filed 10 Feb 2022.